We identified a novel transcription regulation of NRF2 by SOX17, and silencing of SOX17 leads to the activation of NRF2-mediating cytoprotective programs, resulting in CCRT resistance of ESCC cells. This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.